BRPI0920441A2 - acetaminofeno glucuronildado como marcador de doença hepáticas - Google Patents

acetaminofeno glucuronildado como marcador de doença hepáticas

Info

Publication number
BRPI0920441A2
BRPI0920441A2 BRPI0920441A BRPI0920441A BRPI0920441A2 BR PI0920441 A2 BRPI0920441 A2 BR PI0920441A2 BR PI0920441 A BRPI0920441 A BR PI0920441A BR PI0920441 A BRPI0920441 A BR PI0920441A BR PI0920441 A2 BRPI0920441 A2 BR PI0920441A2
Authority
BR
Brazil
Prior art keywords
glucuronylated
acetaminophen
marker
liver disease
liver
Prior art date
Application number
BRPI0920441A
Other languages
English (en)
Inventor
Cherrington Nathan
Original Assignee
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona filed Critical Univ Arizona
Publication of BRPI0920441A2 publication Critical patent/BRPI0920441A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486Analgesics, e.g. opiates, aspirine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/38Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/08Hepato-biliairy disorders other than hepatitis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/08Hepato-biliairy disorders other than hepatitis
    • G01N2800/085Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0920441A 2008-10-01 2009-09-30 acetaminofeno glucuronildado como marcador de doença hepáticas BRPI0920441A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19483508P 2008-10-01 2008-10-01
PCT/US2009/058913 WO2010039754A1 (en) 2008-10-01 2009-09-30 Glucuronidated acetaminophen as a marker of hepatic disorders

Publications (1)

Publication Number Publication Date
BRPI0920441A2 true BRPI0920441A2 (pt) 2017-05-30

Family

ID=41478549

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920441A BRPI0920441A2 (pt) 2008-10-01 2009-09-30 acetaminofeno glucuronildado como marcador de doença hepáticas

Country Status (21)

Country Link
US (2) US20110220500A1 (pt)
EP (1) EP2344892B8 (pt)
JP (2) JP2012504629A (pt)
KR (1) KR20110082148A (pt)
CN (1) CN102227641B (pt)
AU (1) AU2009298669B2 (pt)
BR (1) BRPI0920441A2 (pt)
CA (1) CA2738210A1 (pt)
CL (1) CL2011000654A1 (pt)
DK (1) DK2344892T3 (pt)
ES (1) ES2489016T3 (pt)
HK (1) HK1160223A1 (pt)
IL (1) IL211914A (pt)
MX (1) MX2011003497A (pt)
MY (1) MY156251A (pt)
NZ (1) NZ591981A (pt)
PL (1) PL2344892T3 (pt)
PT (1) PT2344892E (pt)
RU (1) RU2555331C2 (pt)
WO (1) WO2010039754A1 (pt)
ZA (1) ZA201102369B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200393473A1 (en) * 2018-02-26 2020-12-17 Arizona Board Of Regents On Behalf Of The University Of Arizona Ezetimibe metabolite as a non-invasive biomarker for non-alcoholic steatohepatitis (nash)
EP4390397A1 (en) * 2022-12-23 2024-06-26 Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE Methods for diagnosing liver disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7090845B2 (en) * 1998-05-13 2006-08-15 Genentech, Inc. Diagnosis and treatment of hepatic disorders
FI20010019A (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
US7470513B2 (en) * 2003-11-10 2008-12-30 Academia Sinica Risk assessment for adverse drug reactions

Also Published As

Publication number Publication date
KR20110082148A (ko) 2011-07-18
JP2015155913A (ja) 2015-08-27
IL211914A0 (en) 2011-06-30
EP2344892B8 (en) 2014-11-12
ES2489016T3 (es) 2014-09-01
CA2738210A1 (en) 2010-04-08
PL2344892T3 (pl) 2014-10-31
ZA201102369B (en) 2012-09-26
AU2009298669B2 (en) 2016-04-07
CN102227641A (zh) 2011-10-26
AU2009298669A1 (en) 2010-04-08
RU2555331C2 (ru) 2015-07-10
PT2344892E (pt) 2014-08-25
CN102227641B (zh) 2015-04-22
MY156251A (en) 2016-01-29
NZ591981A (en) 2013-05-31
US20110220500A1 (en) 2011-09-15
IL211914A (en) 2015-09-24
MX2011003497A (es) 2011-07-29
EP2344892B1 (en) 2014-05-21
WO2010039754A1 (en) 2010-04-08
JP2012504629A (ja) 2012-02-23
CL2011000654A1 (es) 2011-08-19
RU2011117260A (ru) 2012-11-10
DK2344892T3 (da) 2014-08-18
EP2344892A1 (en) 2011-07-20
US20160209435A1 (en) 2016-07-21
HK1160223A1 (en) 2012-08-10

Similar Documents

Publication Publication Date Title
BRPI0907376A8 (pt) fotobiorreator
BR112012005146A2 (pt) fotobiorreator
IT1397083B1 (it) Marcatore biochimico serico
DK2403814T3 (da) Landbrugsmæssig sammensætning
BRPI0822882A2 (pt) Composição curável
BRPI1009018A2 (pt) fotobiorreator
FI20095300A0 (fi) Kärkiosapipetti
ATE535599T1 (de) Erdbeckenfermenter
BR112012010510A2 (pt) trator
BRPI0910630A2 (pt) utilização de um extrato de mirto como despigmentador
FR2914569B1 (fr) Sorbonne de laboratoire
BRPI0920441A2 (pt) acetaminofeno glucuronildado como marcador de doença hepáticas
FR2953365B1 (fr) Tracteur enjambeur
FR2928612B1 (fr) Tracteur
BRPI1008993A2 (pt) marcadores fecais
SE0701400L (sv) Odlingssystem
FI20080118A0 (fi) Markkerimolekyylejä
ES1070480Y (es) Suelo desmontable
ES1065579Y (es) Marcador manual
BRPI0920894A2 (pt) 1h-benzimidazol-5-carboxamidas como agentes anti-inflamatórios
UA18701S (uk) Тягач
UA18803S (uk) Трактор
FR2916963B1 (fr) Orthese de pouce
UA18120S (uk) Комплект етикеток
UA19296S (uk) Комплект етикеток

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]